tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Imunon, Inc.’s Promising Study on IMNN-001 for Ovarian Cancer: A Market Perspective
PremiumCompany AnnouncementsImunon, Inc.’s Promising Study on IMNN-001 for Ovarian Cancer: A Market Perspective
18d ago
Imunon submits plan in consultation with Nasdaq to ensure compliance
Premium
The Fly
Imunon submits plan in consultation with Nasdaq to ensure compliance
21d ago
Imunon’s Promising OVATION 2 Study Results and Strategic Financial Moves Justify Buy Rating
Premium
Ratings
Imunon’s Promising OVATION 2 Study Results and Strategic Financial Moves Justify Buy Rating
1M ago
Imunon announces data from Phase 2 OVATION 2 study on IMNN-001
PremiumThe FlyImunon announces data from Phase 2 OVATION 2 study on IMNN-001
2M ago
Imunon CEO says company ‘has never been stronger’
Premium
The Fly
Imunon CEO says company ‘has never been stronger’
2M ago
Imunon Faces Nasdaq Delisting Due to Non-Compliance
Premium
Company Announcements
Imunon Faces Nasdaq Delisting Due to Non-Compliance
2M ago
3 Penny Stocks to Watch Now, 5/27/25
PremiumMarket News3 Penny Stocks to Watch Now, 5/27/25
2M ago
Imunon announces up to $9.75M private placement priced at-the-market
Premium
The Fly
Imunon announces up to $9.75M private placement priced at-the-market
2M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100